Next Article in Journal
Aromatic SNF-Approach to Fluorinated Phenyl tert-Butyl Nitroxides
Next Article in Special Issue
Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer’s Disease Pathophysiological Hallmarks
Previous Article in Journal
Nanostructured Silver Coating as a Stationary Phase for Capillary Gas Chromatography
Previous Article in Special Issue
2-Arylidene-1-indandiones as Pleiotropic Agents with Antioxidant and Inhibitory Enzymes Activities

Methyltransferase Inhibitors: Competing with, or Exploiting the Bound Cofactor

Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Rua Arcturus 3, São Bernardo do Campo, SP 09606-070, Brazil
Structural Genomics Consortium, University of Toronto, MaRS Centre, South Tower, 101 College St., Suite 700, Toronto, ON M5G 1L7, Canada
Princess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 2M9, Canada
Department of Pharmacology and Toxicology, University of Toronto, 1 King’s College Circle, Toronto, ON M5S 1A8, Canada
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Orazio Nicolotti
Received: 18 November 2019 / Revised: 3 December 2019 / Accepted: 4 December 2019 / Published: 8 December 2019
(This article belongs to the Special Issue Design, Synthesis, and Biological Evaluation of Enzyme Inhibitors)
Protein methyltransferases (PMTs) are enzymes involved in epigenetic mechanisms, DNA repair, and other cellular machineries critical to cellular identity and function, and are an important target class in chemical biology and drug discovery. Central to the enzymatic reaction is the transfer of a methyl group from the cofactor S-adenosylmethionine (SAM) to a substrate protein. Here we review how the essentiality of SAM for catalysis is exploited by chemical inhibitors. Occupying the cofactor binding pocket to compete with SAM can be hindered by the hydrophilic nature of this site, but structural studies of compounds now in the clinic revealed that inhibitors could either occupy juxtaposed pockets to overlap minimally, but sufficiently with the bound cofactor, or induce large conformational remodeling leading to a more druggable binding site. Rather than competing with the cofactor, other inhibitors compete with the substrate and rely on bound SAM, either to allosterically stabilize the substrate binding site, or for direct SAM-inhibitor interactions. View Full-Text
Keywords: methyltransferases; S-adenosylmethionine; inhibitors; mechanism of action methyltransferases; S-adenosylmethionine; inhibitors; mechanism of action
Show Figures

Figure 1

MDPI and ACS Style

Ferreira de Freitas, R.; Ivanochko, D.; Schapira, M. Methyltransferase Inhibitors: Competing with, or Exploiting the Bound Cofactor. Molecules 2019, 24, 4492.

AMA Style

Ferreira de Freitas R, Ivanochko D, Schapira M. Methyltransferase Inhibitors: Competing with, or Exploiting the Bound Cofactor. Molecules. 2019; 24(24):4492.

Chicago/Turabian Style

Ferreira de Freitas, Renato, Danton Ivanochko, and Matthieu Schapira. 2019. "Methyltransferase Inhibitors: Competing with, or Exploiting the Bound Cofactor" Molecules 24, no. 24: 4492.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop